Contributions of Epstein-Barr Virus EBNA2 and EBNA-LP to B cell immortalization
Contributions of Epstein-Barr Virus EBNA2 and EBNA-LP to B cell immortalization
批准号:
7317804
负责人:
Chisaroka W Echendu
金额:
$2.63万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-01-01 至 2008-07-27
关键词:
Amino AcidsAutoimmune DiseasesB lymphocyte immortalizationB-LymphocytesBindingBiological AssayCell physiologyComplement 3d ReceptorsDNA-Protein InteractionDimerizationDominant-Negative MutationGene ExpressionGenerationsGenesGeneticGenetic TranscriptionHomoHumanHuman Herpesvirus 4In VitroLMP1LengthLocalizedMediatingMethylationModificationMutationOncogene ProteinsRoleTestingTherapeuticTrans-ActivatorsTranscriptional ActivationViralViral Proteinscell transformationinhibitor/antagonistmutantpromotersmall moleculevirus related cancer
中文摘要
项目摘要:Epstein-Barr病毒(EBV)在体外有效地使人类B细胞永生,这需要
病毒蛋白EBNA2和EBNA-LP的表达。EBNA2是病毒和细胞基因的反式激活因子
表情。EBNA-LP是EBNA2的基因特异性共激活因子,它上调主要
病毒癌蛋白LMP1。我们实验室的广泛目标是了解EBNA2和EBNA-LP在
调节促进B细胞永生化的细胞过程。目的1.研究EBNA2的作用
氨基酸残基1-58参与转录激活和B细胞永生化。EBNA2氨基酸残基
1-58对全长EBNA2有显性负效应。EBNA2中的特定突变是保守的
对应于残基1-58的区域(CR)1和2导致缺陷的EBNA2同源齐聚。我们
获得了功能缺陷的突变体,这些突变体也不能齐聚。我们将测试这些
基因互补分析中的突变体保持B细胞永生化的能力。功能性
将在EBV阳性的B细胞中进行检测,以确定这些突变的EBNA2诱导
LMP1。QRT-PCR将用于测试CR1和/或CR2是否介导全局或基因特异性EBNA2
活动。目的2.确定EBNA-LP介导的SplOO从PML NBS置换的机制,
以及这如何有助于EBNA2的共同激活。Spl00氨基酸残基3-152参与二聚反应,
PML Nb定位,以及与EBNA-LP的相互作用。确定EBNA-LP如何重新本地化SplOO
在PML NBS中,SplOO在残基1-2之间引入了连续15个氨基酸缺失。
150.突变体将用于Co-IP和IF检测,以确定介导自
结合,EBNA-LP结合和PML NB定位。EBNA-LP、SplOO和EBNA2的关联,
以及LMP1启动子上的特定修饰(例如甲基化)将由CHIP确定
化验。相关性:靶向齐聚作用的EBNA2小分子抑制剂可能是一个富有成效的药物
EB病毒相关癌症的治疗方法。我们将在中阐明EBNA-LP的机制贡献
B细胞永生化以及SplOO的正常作用,特别是与自身免疫性疾病有关的作用。
英文摘要
Project Summary: Epstein-Barr Virus (EBV) efficiently immortalizes human B cells in vitro and this requires
expression of the viral proteins EBNA2 and EBNA-LP. EBNA2 is a transactivator of viral and cellular gene
expression. EBNA-LP is a gene-specific coactivator of EBNA2, which up-regulates expression of the major
viral oncoprotein LMP1. The broad objective of our lab is to understand the role of EBNA2 and EBNA-LP in
modulating cellular processes that promote B cell immortalization. Aim 1. Investigate the role of EBNA2
amino acid residues 1-58 in transcription activation and B cell immortalization. EBNA2 amino acid residues
1-58 have a dominant negative effect on full length EBNA2. Specific mutations within EBNA2 conserved
regions (CR) 1 and 2, corresponding to residues 1-58, result in defective EBNA2 homo-oligomerization. We
have obtained functionally-deficient mutants which are also unable to oligomerize. We will test these
mutants in genetic complementation assays for their ability to maintain B cell immortalization. Functional
assays will be performed in EBV-positive B cells to determine the ability of these mutant EBNA2 to induce
LMP1. qRT-PCR will be used to test whether CR1 and/or CR2 mediate global or gene-specific EBNA2
activity. Aim 2. Determine the mechanism of EBNA-LP-mediated displacement of SplOO from PML NBs,
and how this contributes to EBNA2 coactivation. SplOO amino acid residues 3-152 mediate dimerization,
PML NB localization, and interactions with EBNA-LP. To determine how EBNA-LP re-localizes SplOO out
of PML NBs, consecutive 15 amino acid deletions have been introduced into SplOO between residues 1-
150. The mutants will be used in Co-IP and IF assays to define critical SplOO residues that mediate self-
association, EBNA-LP binding and PML NB localization. The association of EBNA-LP, SplOO, and EBNA2,
as well as specific modifications (e.g. methylation) on the LMP1 promoter will be determined by ChIP
assays. Relevance: Small molecule inhibitors of EBNA2 function that target oligomerization may be a fruitful
therapeutic approach for EBV-related cancers. We will clarify the mechanistic contributions of EBNA-LP in
B cell immortalization, as well as the normal role of SplOO, especially as related to autoimmune diseases.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Regulation of Sp100A subnuclear localization and transcriptional function by EBNA-LP and interferon.
DOI:
10.1089/jir.2008.0023
发表时间:
2008-10
期刊:
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
影响因子:
--
作者:
[Chisaroka W Echendu;P. Ling]
通讯作者:
Chisaroka W Echendu;P. Ling
Contributions of Epstein-Barr Virus EBNA2 and EBNA-LP to B cell immortalization
-
批准号:7231100
-
项目类别:
-
资助金额:$3.14万
-
财政年份:2007
-
负责人:Chisaroka W Echendu
-
依托单位:
国内基金
海外基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
-
批准号:31171277
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:Christine Nardini
-
依托单位: